Real-world results confirm the benefits of dosing ZOMETA^® every 3 to
4 weeks in patients like Marta¹⁵

Rate of SREs by dosing regimen^15*

*There are limitations to this study because the results are from a retrospective claims database analysis.

Treatment with ZOMETA 4 mg every 3 to 4 weeks significantly reduced the rate of skeletal morbidity (measured as number of events per month) vs no treatment¹⁵
No other dosing schedule is proven to protect patients from SREs^4,7,13,14

Using alternative dosing schedules significantly compromises the
benefits of ZOMETA¹⁵

Page

1 2 3 4

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

Real-world results confirm the benefits of dosing ZOMETA® every 3 to 4 weeks in patients like Marta15

Using alternative dosing schedules significantly compromises thebenefits of ZOMETA15

Real-world results confirm the benefits of dosing ZOMETA^® every 3 to
4 weeks in patients like Marta¹⁵

Using alternative dosing schedules significantly compromises the
benefits of ZOMETA¹⁵